We've always been lucky at HealthHack to recruit wonderful judges and 2018 is no exception to that trend. Here are the 2018 judges of Brisbane HealthHack.
Jason Lowe
Twitter: @jlowe000
Linkedin: https://www.linkedin.com/in/lowe-jason/
Jason Lowe is one of the Co-Founders of Hacking Health Queensland, a chapter of Hacking Health Global which is a not-for-profit organisation acting both locally & globally to connect stakeholders, enable #innovation, #entrepreneurship, & change, to improve #health for all. Jason spends his time during the day working at Oracle heading up #AppDev and #DevOps initiatives in the region and contributes to the community building activities in the Oracle ecosystem, the health ecosystem with Hacking Health and within the corporate / startup ecosystem.
Kate Devitt
Twitter: @skdevitt
LinkedIn: https://www.linkedin.com/in/skdevitt/
Kate Devitt is a philosopher and cognitive scientist researching and building ethical, research-backed and engaging decision support systems for adoption. She is co-founder and CEO of BetterBeliefs, a social platform for evidence-based strategic decision making. Based on Bayesian rationality, BetterBeliefs clients include a global online travel company and a QLD emergency services organisation. Her research includes: the ethics of decision support tools, barriers to the adoption of digital agricultural technologies; the trustworthiness of autonomous systems; and the impact of agricultural robots on human rights
Professor Ranjeny Thomas
MBBS (WA), MD (WA), FRACP, FAAHMS
Professor Thomas is Professor of Rheumatology at University of Queensland, Translational Research Institute, consultant rheumatologist at Princess Alexandra Hospital and fellow of the Australian Academy of Health and Medical Sciences.
Her research seeks to understand autoimmune disease and restoration of immune tolerance. Through this work, she developed and tested the first rheumatoid arthritis vaccine. She has also contributed major insights into how the microbiome is involved in causing spondyloarthropathy leading to the development of disease biomarkers and therapeutic strategies. Ranjeny is founder and a director of the spin-off company, Dendright, which is developing immunotherapy for autoimmune diseases.